Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy Article

Wang, Ting, Li, Qianyao, Xu, Rui et al. (2024). Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy . FRONTIERS IN PHARMACOLOGY, 15 10.3389/fphar.2024.1437071

Open Access

cited authors

  • Wang, Ting; Li, Qianyao; Xu, Rui; Zhao, Zixuan; Sun, Qi; Xu, Xiaoding; Li, Rong

sustainable development goals

authors

publication date

  • July 30, 2024

published in

keywords

  • CANCER
  • Life Sciences & Biomedicine
  • NONCODING RNAS
  • Pharmacology & Pharmacy
  • SIRNA DELIVERY
  • Science & Technology
  • chemotherapy
  • co-delivery
  • lncRNA
  • nanoplatform
  • resistance

Digital Object Identifier (DOI)

publisher

  • FRONTIERS MEDIA SA

volume

  • 15